Hologic Reports 7 Percent Increase in Preliminary Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Hologic said today that it expects to report total revenues of $653 million for its fiscal first quarter ending Dec. 31, 2014.

The preliminary revenues represent a 7 percent increase over the prior-year period and exceed the company's previous quarterly revenue guidance of $625 million to $635 million. The projected revenues also beat consensus analyst estimates of $631 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.